CVS Health reported a strong third quarter with a 47% increase in adjusted EPS to $1.60 and record revenues of $103 billion. The company raised its full-year adjusted EPS guidance to $6.55-$6.65. Trends show strong performance in Health Care Benefits and Pharmacy & Consumer Wellness segments, positioning CVS for continued growth.

Amazon’s third-quarter net sales rose 13% to $180.2 billion, with AWS segment sales growing 20.2%. Elevance Health reported operating revenues of $50.1 billion, up 12% year over year. Both companies are confident in their future performance and have reaffirmed their adjusted EPS guidance for 2025.

CVS Health stock has rallied 43.5% in the past year, outperforming the industry. The company’s forward P/S ratio is 0.23, lower than the industry average of 0.45. Analysts are optimistic about CVS Health’s earnings outlook for 2025 and 2026, with a current Zacks Rank of #3 (Hold).

The AI revolution is entering its second wave, with lesser-known AI firms potentially offering more lucrative opportunities than well-known tech giants. Investors are encouraged to explore these “2nd Wave” AI stocks for potential profits in the coming months and years.

Read more at Nasdaq: CVS Health Lifts Adjusted EPS Outlook: What’s Driving It?